Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: Re: MannKind Corporation Implements BioPharm Systems’ Siebel Clinical Trial

I suppose Ron would say "if the trials were going well, why would they need support from a 3rd party vendor?"

Or, you could say "MNKD's willingness to make such an expenditure is growing evidence of their confidence in Afrezza's success."

Share
New Message
Please login to post a reply